Pfizer Inc
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Pfizer Inc reported 23 stock positions worth $2.6 billion. Its top holding was Haleon PLC-ADR (HLN) at 72.6% of the portfolio, followed by Biontech SE-ADR (BNTX, 16.1%) and Arvinas (ARVN, 2.6%).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0000078003
- Portfolio Value
- $2.6B (Q4 2024)
- SEC Filing
- 0000078003-25-000048 ↗ filed Feb 14, 2025
Holdings Value
Holdings 23 stocks · $2.6B
| HLN Haleon PLC-ADR | 72.59% | 197,228,952 | $1.9B | — |
| BNTX Biontech SE-ADR | 16.08% | 3,658,361 | $416.9M | — |
| ARVN Arvinas Inc. | 2.56% | 3,457,815 | $66.3M | — |
| ALLO Allogene Therapeutics Inc. | 1.81% | 22,032,040 | $46.9M | — |
| ORIC Oric Pharmaceuticals Inc. | 1.67% | 5,376,344 | $43.4M | — |
| TRML Tourmaline Bio Inc. | 1.00% | 1,272,214 | $25.8M | — |
| WVE Wave Life Sciences Ltd. | 0.89% | 1,875,000 | $23.2M | — |
| BHVN Biohaven Ltd. | 0.73% | 505,645 | $18.9M | — |
| AKRO Akero Therapeutics Inc. | 0.60% | 562,626 | $15.7M | — |
| PYXS Pyxis Oncology Inc. | 0.42% | 7,032,770 | $11.0M | — |
| CRDF Cardiff Oncology Inc. | 0.40% | 2,411,575 | $10.5M | — |
| CRBU Caribou Biosciences Inc. | 0.29% | 4,690,431 | $7.5M | — |
| ZURA Zura Bio Ltd. | 0.29% | 2,970,022 | $7.4M | — |
| CELC Celcuity Inc. | 0.18% | 349,406 | $4.6M | — |
| EPIX Essa Pharma Inc. | 0.12% | 1,675,000 | $3.0M | — |
| ZNTL Zentalis Pharmaceuticals Inc. | 0.11% | 953,834 | $2.9M | — |
| SPRO Spero Therapeutics Inc. | 0.09% | 2,362,348 | $2.4M | — |
| NXTC Nextcure Inc. | 0.07% | 1,458,550 | $1.9M | — |
| ANTX AN2 Therapeutics Inc. | 0.04% | 715,295 | $987K | — |
| QTTB Q32 Bio Inc. | 0.04% | 277,777 | $956K | — |
| BOLT Bolt Biotherapeutics Inc. | 0.01% | 626,109 | $335K | — |
| DNA Ginkgo Bioworks Holdings Inc. | 0.00% | 2,928 | $29K | — |
| SENS Senseonics Holdings Inc. | 0.00% | 43,426 | $23K | — |
Portfolio Sells Q4 2024
No earlier filing to compare with.
Portfolio Buys Q4 2024
No earlier filing to compare with.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 17 | $170.4M | ALLO, CELC, ARVN, PYXS, WVE |
| Q1 2026 | 18 | $238.8M | ORIC, ALLO, ARVN, CELC, ZURA |
| Q4 2025 | 18 | $236.5M | ORIC, ARVN, CELC, WVE, ALLO |
| Q3 2025 | 21 | $437.5M | BNTX, ORIC, TRML, ARVN, ALLO |
| Q2 2025 | 21 | $576.2M | BNTX, ORIC, ARVN, ALLO, TRML |
| Q1 2025 | 21 | $500.8M | BNTX, ALLO, ORIC, ARVN, TRML |
| Q4 2024 | 23 | $2.6B | HLN, BNTX, ARVN, ALLO, ORIC |